Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes

NCT02481141 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: 5-ALA-SFC
DRUG: Placebo

Sponsor

SBI Pharmaceuticals Co, Ltd.